Glenmark Pharmaceuticals Ltd vs Sigachi Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 2034 as of 17 Feb 12:23 . The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 13.5 on March 2021 to 41.5 on March 2025 . This represents a CAGR of 25.18% over 5 yearsThe P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 19.3 on March 2025 . This represents a CAGR of -3.44% over 4 years The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 13108 crore on March 2021 to ₹ 43458 crore on March 2025 . This represents a CAGR of 27.09% over 5 yearsThe Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1342 crore on March 2025 . This represents a CAGR of 10.85% over 4 years The revenue of Glenmark Pharmaceuticals Ltd for the Dec '25 is ₹ 3945 crore as compare to the Sep '25 revenue of ₹ 6247 crore. This represent the decline of -36.85% The revenue of Sigachi Industries Ltd for the Dec '25 is ₹ 117.68 crore as compare to the Sep '25 revenue of ₹ 117.63 crore. This represent the growth of 0.04% The ebitda of Glenmark Pharmaceuticals Ltd for the Dec '25 is ₹ 729.88 crore as compare to the Sep '25 ebitda of ₹ 1175 crore. This represent the decline of -37.89% The ebitda of Sigachi Industries Ltd for the Dec '25 is ₹ 5.45 crore as compare to the Sep '25 ebitda of ₹ 14.67 crore. This represent the decline of -62.85% The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 340.24 crore to ₹ 403.23 crore over 7 quarters. This represents a CAGR of 10.19% The net profit of Sigachi Industries Ltd changed from ₹ 12.76 crore to ₹ -0.02 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 4.28 % on March 2021 to 4.38 % on March 2025 . This represents a CAGR of 0.46% over 5 yearsThe Dividend Payout of Sigachi Industries Ltd changed from 8.08 % on March 2022 to 8.02 % on March 2025 . This represents a CAGR of -0.19% over 4 years .

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
Its branded generics business has a significant presence in markets across emerging economies including India.

About Sigachi Industries Ltd

Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
To diversify the business activities, the name of Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
Subsequently, it was converted from a Private Limited to a Public Limited and the name was changed to 'Sigachi Industries Limited' on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Sigachi Industries Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Sigachi Industries Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 68,294 Cr while Market cap of Sigachi Industries Ltd is 768 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Sigachi Industries Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Sigachi Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Sigachi Industries Ltd?

As of May 5, 2026, the Glenmark Pharmaceuticals Ltd stock price is INR ₹2420.05. On the other hand, Sigachi Industries Ltd stock price is INR ₹20.12.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Sigachi Industries Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Sigachi Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.